Pharmstandard International S.A.

Q4 2016 13F Holdings Report, Options Holdings

Signature - Title
Eriks Martinovskis - Director
Location
Luxembourg, Luxembourg
Options holdings as of
December 31, 2016
Notional value $
$27.4M
Number of holdings
1
Date filed
2/13/2017, 08:02 PM
Description
All US holdings of this investor are reported in this report.
Next filing
Q1 2017 - Aug 17, 2017
Stock holdings
Showing options holdings, see here for stock holdings
Sym Company Class Option Share Change Activity * Price $ Shares Notional Value
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Eriks Martinovskis Director Luxembourg, Luxembourg 2/10/2017

Other Included Managers (1):

Num Name Location File Number
1 Public Joint Stock Co Pharmstandard